World Health Organization. Obesity and overweight [Internet]. Geneva: World Health Organization. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245–50. https://doi.org/10.1161/01.CIR.0000140677.20606.0E.
Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care. 2005;28:1769–78. https://doi.org/10.2337/diacare.28.7.1769.
Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607. https://doi.org/10.2337/diab.37.12.1595.
Article CAS PubMed Google Scholar
DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–94. https://doi.org/10.2337/diacare.14.3.173.
Article CAS PubMed Google Scholar
DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard lecture 2009. Diabetologia. 2010;53(7):1270–87. https://doi.org/10.1007/s00125-010-1684-1.
Article CAS PubMed PubMed Central Google Scholar
Kurinami N, Sugiyama S, Yoshida A, Hieshima K, Miyamoto F, Kajiwara K, et al. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naïve type 2 diabetes mellitus. Diabetes Res Clin Pract. 2016;120:65–72. https://doi.org/10.1016/j.diabres.2016.07.018.
Article CAS PubMed Google Scholar
Kurinami N, Sugiyama S, Morita A, Yoshida A, Hieshima K, Miyamoto F, et al. Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018;139:122–30. https://doi.org/10.1016/j.diabres.2018.02.009.
Kurinami N, Sugiyama S, Ijima H, Yoshida A, Hieshima K, Miyamoto F, et al. Clinical usefulness of the body muscle-to-fat ratio for screening obstructive sleep apnea syndrome in patients with inadequately controlled type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018;143:134–9. https://doi.org/10.1016/j.diabres.2018.07.008.
Kurinami N, Sugiyama S, Yoshida A, Hieshima K, Miyamoto F, Kajiwara K, et al. Body muscle-to-fat ratio gender-specific cut-off values for impaired insulin sensitivity in patients with treatment-naïve type 2 diabetes mellitus. Endocrine. 2019;66(3):503–8. https://doi.org/10.1007/s12020-019-02092-8.
Article CAS PubMed Google Scholar
Kurinami N, Sugiyama S, Yoshida A, Hieshima K, Miyamoto F, Kajiwara K, et al. Body muscle-to-fat ratio, rather than fat-to-muscle ratio, significantly correlates with measured insulin resistance in patients with type 2 diabetes mellitus. J Clin Med Res. 2021;13(7):387–91. https://doi.org/10.14740/jocmr4401.
Article CAS PubMed PubMed Central Google Scholar
Guan Z, Minnetti M, Heymsfield SB, Poggiogalle E, Prado CM, Sim M, et al. Beyond traditional body composition metrics: Load-Capacity indices emerge as predictors of cardiometabolic outcomes. Adv Nutr. 2025;16:100364. https://doi.org/10.1016/j.advnut.2024.100364.
Article CAS PubMed PubMed Central Google Scholar
Oliver CJ, Climstein M, Rosic N, Bosy-Westphal A, Tinsley G, Myers S. Fat-Free mass: friend or foe to metabolic health? J Cachexia Sarcopenia Muscle. 2025;16(1):e13714. https://doi.org/10.1002/jcsm.13714.
Article PubMed PubMed Central Google Scholar
Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32(6):959–66. https://doi.org/10.1038/ijo.2008.11.
Article CAS PubMed Google Scholar
Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34(5):791–9. https://doi.org/10.1038/ijo.2010.5.
Article CAS PubMed Google Scholar
De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol. 2016;22(2):681–703. https://doi.org/10.3748/wjg.v22.i2.681.
Article CAS PubMed PubMed Central Google Scholar
Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr. 2012;31(5):583–601. https://doi.org/10.1016/j.clnu.2012.06.010.
Article CAS PubMed Google Scholar
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond). 2008: 32 Suppl 3:S56-9. https://doi.org/10.1038/ijo.2008.87
Burton RF. Waist circumference as an indicator of adiposity and the relevance of body height. Med Hypotheses. 2010;75(2):115–7. https://doi.org/10.1016/j.mehy.2010.02.003.
Article CAS PubMed Google Scholar
Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Obes Rev. 2011;12(9):680–7. https://doi.org/10.1111/j.1467-789X.2011.00879.x.
Article CAS PubMed PubMed Central Google Scholar
Riaz M, Lodhi S. Beyond BMI. Exploring obesity trends in the South Asian region. Obesity Pillars. 2025;13:100156. https://doi.org/10.1016/j.obpill.2024.100156.
World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8–11 December 2008. Geneva: World Health Organization. 2011. Available from: https://iris.who.int/handle/10665/44583
Song X, Jousilahti P, Stehouwer CD, Söderberg S, Onat A, Laatikainen T, et al. Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality. Eur J Clin Nutr. 2013;67(12):1298–302. https://doi.org/10.1038/ejcn.2013.203.
Article CAS PubMed Google Scholar
DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S157–63. https://doi.org/10.2337/dc09-S302.
Article CAS PubMed PubMed Central Google Scholar
Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84(3):475–82. https://doi.org/10.1093/ajcn/84.3.475.
Article CAS PubMed Google Scholar
Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31–55. https://doi.org/10.1016/j.immuni.2021.12.013.
Article CAS PubMed PubMed Central Google Scholar
Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the fourth Korean national health and nutritional examination surveys. J Gerontol A Biol Sci Med Sci. 2012;67(10):1107–13. https://doi.org/10.1093/gerona/gls071.
Lu Z, Hu Y, Chen X, Ou Q, Liu Y, Xu T, et al. Sex-specific associations between total and regional fat-to-muscle mass ratio and cardiometabolic risk: findings from the China National health survey. Nutr J. 2024;23(1):104. https://doi.org/10.1186/s12937-024-01007-2.
Article CAS PubMed PubMed Central Google Scholar
Wang N, Sun Y, Zhang H, Chen C, Wang Y, Zhang J, et al. Total and regional fat-to‐muscle mass ratio measured by bioelectrical impedance and incident type 2 diabetes J. Cachexia Sarcopenia Muscle. 2021;12(6):2154–62. https://doi.org/10.1002/jcsm.12822.
Chen YY, Fang WH, Wang CC, Kao TW, Yang HF, Wu CJ, et al. Fat-to-muscle ratio is a useful index for cardiometabolic risks: a population-based observational study. PLoS
Comments (0)